AI in Pharmacovigilance Market to Reach USD 1.9 Billion by 2035 | AI, Machine Learning & Drug Safety Analytics Drive Industry Growth

➤ Market Overview

According to MarketGenics, the global AI in Pharmacovigilance Market was valued at USD 0.4 billion in 2025 and is projected to reach USD 1.9 billion by 2035, registering a CAGR of 17.1% during the forecast period (2025-2035). The market is experiencing significant growth due to the increasing demand for automated adverse event detection, growing complexity of drug safety monitoring, and expanding adoption of artificial intelligence (AI), machine learning (ML), and natural language processing (NLP) across pharmaceutical and biotechnology companies. AI-powered pharmacovigilance solutions help organizations streamline case processing, signal detection, risk assessment, regulatory compliance, and post-market surveillance while reducing operational costs and improving patient safety. Rising drug development activities, stringent regulatory requirements, and the growing volume of real-world healthcare data are further accelerating market growth globally.

Get Free Sample PDF Brochure: https://marketgenics.co/download-report-sample/ai-in-pharmacovigilance-market-59587?utm_source=Open+pr&utm_medium=ruchika

➤ Growth Snapshot (2025-2035)

The AI in Pharmacovigilance Market is expected to witness robust double-digit growth throughout the forecast period, driven by increasing investments in AI-enabled drug safety platforms and digital healthcare transformation. The market is projected to grow from USD 0.4 billion in 2025 to USD 1.9 billion by 2035, expanding at a CAGR of 17.1%. North America currently dominates the market owing to strong pharmaceutical R&D investments and early adoption of AI technologies, while Asia-Pacific is expected to register the fastest growth due to expanding clinical research activities, growing pharmaceutical manufacturing, and increasing healthcare digitization.

➤ Market Key Players

• IQVIA Inc.
• Oracle Corporation
• ArisGlobal LLC
• Cognizant Technology Solutions
• Wipro Limited
• Tata Consultancy Services (TCS)
• Capgemini SE
• Saama Technologies, LLC
• IBM Corporation
• Parexel International Corporation
• Labcorp Drug Development
• Veeva Systems Inc.
• Genpact Limited
• ICON plc

Buy Now Premium Research Report: https://marketgenics.co/buy/ai-in-pharmacovigilance-market-59587?utm_source=Open+pr&utm_medium=ruchika

➤ Market Segmentation

The AI in Pharmacovigilance Market is segmented based on component, deployment mode, technology, application, end user, and region. By component, the market includes software platforms and professional services. Based on deployment mode, it comprises cloud-based and on-premises solutions. By technology, the market includes machine learning, natural language processing (NLP), deep learning, robotic process automation (RPA), and predictive analytics. Applications include adverse event reporting, signal detection, case processing, risk management, literature monitoring, regulatory compliance, and post-marketing surveillance. End users include pharmaceutical companies, biotechnology firms, contract research organizations (CROs), regulatory agencies, hospitals, healthcare providers, and life sciences organizations.

➤ Market Analysis and Insights

The AI in Pharmacovigilance Market is transforming drug safety management by automating traditionally manual pharmacovigilance processes and improving the speed and accuracy of adverse event detection. AI-powered algorithms are enabling pharmaceutical companies to process vast amounts of structured and unstructured healthcare data from electronic health records, clinical trials, scientific literature, and social media platforms. Natural language processing is significantly improving literature screening and adverse event identification, while machine learning models are enhancing predictive risk assessment and regulatory reporting. As regulatory agencies continue to emphasize patient safety and faster reporting timelines, organizations are increasingly investing in AI-driven pharmacovigilance platforms to improve operational efficiency, ensure compliance, and support faster drug development.

➤ Segmentation and Targeting

The report is designed for pharmaceutical manufacturers, biotechnology companies, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), healthcare IT providers, regulatory agencies, hospitals, life sciences companies, AI software developers, cloud service providers, consulting firms, investors, research institutions, and digital health organizations. It provides comprehensive insights into market trends, competitive benchmarking, technology adoption, regulatory developments, regional opportunities, and long-term investment strategies within the global AI in pharmacovigilance industry.

Browse In-depth Market Research Report: https://marketgenics.co/reports/ai-in-pharmacovigilance-market-59587?utm_source=Open+pr&utm_medium=ruchika

➤ Geographical Landscape

North America dominates the AI in Pharmacovigilance Market due to advanced pharmaceutical research infrastructure, strong regulatory frameworks, and widespread adoption of AI technologies across the United States and Canada. Europe, including Germany, the United Kingdom, France, Switzerland, Italy, and the Netherlands, continues to witness strong market growth supported by robust life sciences industries and stringent pharmacovigilance regulations. Asia-Pacific is projected to register the fastest growth, driven by increasing pharmaceutical production, expanding clinical trials, healthcare digitization, and AI adoption in China, India, Japan, South Korea, Singapore, and Australia. Latin America, particularly Brazil and Mexico, is witnessing growing investments in pharmaceutical research and regulatory modernization. Meanwhile, the Middle East & Africa, led by Saudi Arabia, the UAE, Israel, and South Africa, are gradually adopting AI-driven drug safety solutions to strengthen healthcare systems and regulatory compliance.

➤ Questions Answered by the Report

The report answers key industry questions, including the projected market value of the AI in Pharmacovigilance Market by 2035, expected CAGR during the forecast period, major growth drivers, leading technology and application segments, fastest-growing regional markets, competitive landscape, advancements in AI, NLP, machine learning, and predictive analytics, regulatory developments, investment opportunities, emerging drug safety trends, and strategic initiatives adopted by leading companies to strengthen their position in the global AI in pharmacovigilance market.

➤ Discover More Research Reports By MarketGenics:

Crop Monitoring Market - https://www.openpr.com/news/4581544/crop-monitoring-market-to-reach-usd-14-billion-by-2035-u-s

Agricultural Robotics Market - https://www.openpr.com/news/4581553/agricultural-robotics-market-to-reach-usd-21-2-billion-by-2035

Livestock Monitoring Market - https://www.openpr.com/news/4581581/livestock-monitoring-market-to-reach-usd-2-7-billion-by-2035

Vertical Farming Market - https://www.openpr.com/news/4582029/vertical-farming-market-to-reach-usd-17-2-billion-by-2035-u-s

Precision Agriculture Market - https://www.openpr.com/news/4582031/precision-agriculture-market-to-reach-usd-6-9-billion-by-2035

About MarketGenics

MarketGenics is a global market research and business advisory firm empowering decision-makers across startups, Fortune 500 companies, non-profit organizations, universities, and government institutions. The company delivers comprehensive market intelligence, industry analysis, and strategic insights across diverse sectors.

MarketGenics publishes detailed industry research reports combining granular quantitative analysis with expert insights on market trends, competitive landscapes, and emerging opportunities. These reports help organizations make informed strategic decisions, identify growth opportunities, and support sustainable business development.

In addition to research publications, MarketGenics supports organizations with strategic insights on product development, application modeling, market expansion strategies, and identifying niche growth opportunities.

Contact:
Mr. Debashish Roy
MarketGenics Global Research

800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States

USA: +1 (302) 303-2617
Email: sales@marketgenics.co
Website: https://marketgenics.co

This release was published on openPR.